Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users

Psychological Medicine

Volumn 38, Issue 9, 2008, Pages 1309-1317

  Schilt, T ^a,b   De Win, M M L ^a   Jager, G ^c   Koeter, M W ^a,b   Ramsey, N F ^c   Schmand, B ^a   Van Den Brink, W ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cannabis; Cognition; Ecstasy; MDMA; Memory; Neuropsychology; Neurotoxicity; Polydrug use

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; ECSTASY; ILLICIT DRUG;

ADULT; ARTICLE; ATTENTION; COGNITION; DEPTH PERCEPTION; DRUG USE; FEMALE; HUMAN; MALE; MULTIPLE REGRESSION; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; RECALL; SUBSTANCE ABUSE; WORKING MEMORY;

ADOLESCENT; ADULT; AMPHETAMINE; ATTENTION; CANNABIS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COGNITION; COGNITION DISORDERS; FEMALE; HALLUCINOGENS; HUMANS; MALE; MEMORY, SHORT-TERM; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; SPACE PERCEPTION; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; VERBAL BEHAVIOR; VISUAL PERCEPTION;

EID: 48749125721     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291707002140     Document Type: Article

References (44)

1. Benton AL, Varney NR, Hamsher KD (1978). Visuospatial judgment. A clinical test. Archives of Neurology 35, 364-367.
2. Bolla KI, McCann UD, Ricaurte GA (1998). Memory impairment in abstinent MDMA ('ecstasy') users. Neurology 51, 1532-1537.
3. Bolla KI, Rothman R, Cadet JL (1999). Dose-related neurobehavioral effects of chronic cocaine use. Journal of Neuropsychiatry and Clinical Neurosciences 11, 361-369.
4. Burgess PW, Shallice T (1996). Confabulation and the control of recollection. Memory 4, 359-411.
5. Compton WM, Thomas YF, Conway KP, Colliver JD (2005). Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry 162, 1494-1502.
6. Croft RJ, Mackay AJ, Mills AT, Gruzelier JG (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology (Berlin) 153, 373-379.
7. Dafters RI, Hoshi R, Talbot AC (2004). Contribution of cannabis and MDMA ('ecstasy') to cognitive changes in long-term polydrug users. Psychopharmacology (Berlin) 173, 405-410.
8. de Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, den Heeten GJ, Ramsey NF, Korf DJ, van den Brink W (2005). The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research 14, 167-185.
9. Drugs Informatie en Monitoring System (2004). Jaarbericht 2004. DIMS/Trimbos-instituut: Utrecht, The Netherlands.
10. Fox HC, Toplis AS, Turner JJ, Parrott AC (2001). Auditory verbal learning in drug-free ecstasy polydrug users. Human Psychopharmacology 16, 613-618.
11. Gouzoulis-Mayfrank E, Daumann J (2006a). Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101, 348-361.
12. Gouzoulis-Mayfrank E, Daumann J (2006b). The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Journal of Psychopharmacology 20, 188-193.
13. Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacological and Biological Psychiatry 27, 819-827.
14. Graham FK, Kendall BS (1960). Memory-for-design: revised general manual. Perceptual and Motor Skills 11, 147-188.
15. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacological Reviews 55, 463-508.
16. Gronwall DM (1977). Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and Motor Skills 44, 367-373.
17. Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J (2000). Neuroprotective antioxidants from marijuana. Annals of the New York Academy of Science 899, 274-282.
18. Huisman S (2005). Criminaliteitsbeeldanalyse Synthetische Drugs 2002-2004. Korps Landelijke Politiediensten/Dienst Nationale Recherche (KLPD/NR): Driebergen.
19. Lindeboom J, Matto D (1994). Digit series and Knox cubes as concentration tests for elderly subjects [in Dutch]. Tijdschrift voor Gerontologie en Geriatrie 25, 63-68.
20. McKetin R, Mattick RP (1998). Attention and memory in illicit amphetamine users: comparison with non-drug-using controls. Drug and Alcohol Dependence 50, 181-184.
21. Medina KL, Shear PK, Corcoran K (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective. Journal of the International Neuropsychological Society 11, 753-765.
22. Meneses A (1999). 5-HT system and cognition. Neuroscience and Biobehavioral Reviews 23, 1111-1125.
23. Montgomery C, Fisk JE, Newcombe R (2005a). The nature of ecstasy-group related deficits in associative learning. Psychopharmacology (Berlin) 180, 141-149.
24. Montgomery C, Fisk JE, Newcombe R, Murphy PN (2005b). The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology (Berlin) 182, 262-276.
25. Moscovitch M, Melo B (1997). Strategic retrieval and the frontal lobes: evidence from confabulation and amnesia. Neuropsychologia 35, 1017-1034.
26. Nabben T, Quaak L, Korf DJ (2005). NL. Trendwatch. Gebruikersmarkt uitgaansdrugs in Nederland 2004-2005. Rozenberg Publishers: Amsterdam.
27. Nelson HE, O'Connell A (1978). Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234-244.
28. Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J (2002). Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology 17, 309-312.
29. Parrott AC, Gouzoulis-Meyfrank E, Rodgers J, Solowij N (2004). Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects. Journal of Psychopharmacology 18, 572-575.
30. Pedersen W, Skrondal A (1999). Ecstasy and new patterns of drug use: a normal population study. Addiction 94, 1695-1706.
31. Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ (2006). Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology 20, 164-175.
32. Rey A (1964). L'Examen Clinique en Psychologie. Presses Universitaires de France: Paris.
33. Ricaurte GA, Yuan J, McCann UD (2000). (±)3,4- Methylenedioxymethamphetamine ('ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42, 5-10.
34. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC (2003). Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. Journal of Psychopharmacology 17, 389-396.
35. Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry 64, 728-736.
36. Schmand B, Bakker D, Saan R, Louman J (1991). The Dutch Reading Test for Adults: a measure of premorbid intelligence level [in Dutch]. Tijdschrift voor Gerontologie en Geriatrie 22, 15-19.
37. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22-33.
38. Shepard RN, Metzler J (1971). Mental rotation of three-dimensional objects. Science 171, 701-703.
39. Sinor AD, Irvin SM, Greenberg DA (2000). Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neuroscience Letters 278, 157-160.
40. Sprague JE, Everman SL, Nichols DE (1998). An integrated hypothesis for the serotonergic axonal loss induced by 3,4- methylenedioxymethamphetamine. Neurotoxicology 19, 427-441.
41. Topp L, Barker B, Degenhardt L (2004). The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 73, 33-40.
42. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2005). Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. Journal of the International Neuropsychological Society 11, 290-302.
43. van Ours JC (2005). Ecstasy and cocaine: patterns of use among prime age individuals in Amsterdam. Addictive Behaviors 30, 1468-1473.
44. Wechsler D (1981). WAIS-R Manual. The Psychological Corporation: San Antonio, TX.